Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lange

Showing results (961-970 of 1,082) with videos related to

Pageof 109
Sort By:
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2016
Optimization of N'-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocketArnold van Loevezijn, Jennifer Venhorst, Wouter I Iwema Bakker, et al.
Neurobiology of Learning and Memory|June 28, 2016
The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairmentN M W J de Bruin, A van Loevezijn, K M Wicke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS PlacementMarlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Archives of Internal Medicine|September 26, 2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort studyP T Nieuwkerk, M A Sprangers, D M Burger, et al.
International Journal of Obesity (2005)|December 3, 2022
Gene expression associations with body mass index in the Multi-Ethnic Study of AtherosclerosisLuciana B Vargas, Leslie A Lange, Kendra Ferrier, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
Circulation. Genomic and Precision Medicine|October 28, 2021
Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black AdultsNels C Olson, Laura M Raffield, Anne H Moxley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKSKristin S Levine, Lana Sargent, Emma N Somerville, et al.
Cardiovascular and Interventional Radiology|August 2, 2023
Outcome of Children with Transjugular Intrahepatic Portosystemic Shunt: A Meta-Analysis of Individual Patient DataSinan Deniz, Regina Schinner, Eric J Monroe, et al.
Pageof 109

Showing results (961-970 of 1,082) with videos related to

Sort By:
Pageof 109
AIDS (London, England)|November 8, 2001
Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune statusA M van Rossum, H J Scherpbier, E G van Lochem, et al.
Bioorganic & Medicinal Chemistry Letters|February 16, 2016
Optimization of N'-(arylsulfonyl)pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocketArnold van Loevezijn, Jennifer Venhorst, Wouter I Iwema Bakker, et al.
Neurobiology of Learning and Memory|June 28, 2016
The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairmentN M W J de Bruin, A van Loevezijn, K M Wicke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS PlacementMarlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Archives of Internal Medicine|September 26, 2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort studyP T Nieuwkerk, M A Sprangers, D M Burger, et al.
International Journal of Obesity (2005)|December 3, 2022
Gene expression associations with body mass index in the Multi-Ethnic Study of AtherosclerosisLuciana B Vargas, Leslie A Lange, Kendra Ferrier, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
Circulation. Genomic and Precision Medicine|October 28, 2021
Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black AdultsNels C Olson, Laura M Raffield, Anne H Moxley, et al.
Medrxiv : the Preprint Server for Health Sciences|July 17, 2025
MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKSKristin S Levine, Lana Sargent, Emma N Somerville, et al.
Cardiovascular and Interventional Radiology|August 2, 2023
Outcome of Children with Transjugular Intrahepatic Portosystemic Shunt: A Meta-Analysis of Individual Patient DataSinan Deniz, Regina Schinner, Eric J Monroe, et al.
Pageof 109